Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Hartford International Opp HLS IB HBIOX
- NAV / 1-Day Return 16.15 / +0.31 %
- Total Assets 862.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.80%
- Turnover 54%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:14 PM GMT+0
Morningstar’s Analysis HBIOX
Will HBIOX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 3.51 | 30.8 Mil | Technology |
Samsung Electronics Co Ltd | 3.32 | 29.1 Mil | Technology |
ASML Holding NV | 2.49 | 21.8 Mil | Technology |
Tencent Holdings Ltd | 2.34 | 20.6 Mil | Communication Services |
AstraZeneca PLC | 2.24 | 19.6 Mil | Healthcare |
Shell PLC | 2.20 | 19.3 Mil | Energy |
Novo Nordisk A/S Class B | 2.07 | 18.2 Mil | Healthcare |
Novartis AG Registered Shares | 1.97 | 17.3 Mil | Healthcare |
Mitsubishi UFJ Financial Group Inc | 1.88 | 16.5 Mil | Financial Services |
Siemens AG | 1.88 | 16.5 Mil | Industrials |